Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

CAPRCAPR
Showing 5 of 7 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in CAPRICOR THERAPEUTICS INC

BALYASNY ASSET MANAGEMENT L.P. holds 486,836 shares of CAPR (CAPRICOR THERAPEUTICS INC), worth $11.7M as of 2026-Q2. The position was increased (+63.9% shares). CAPR represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$11.7M

Current Shares

486,836

Total Value Change

+$11.5M

Total Shares Change

+471,837

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
486,836
+63.9%
$11.7M0.0%$24.08
41
2026-Q1
Decreased
297,123
-15.8%
$9M0.0%$25.84
0
2025-Q4
New
352,998
-
$10.2M0.0%$28.96
38
2024-Q4
Exited
0
-100.0%
$00.0%$13.76
0
2024-Q3
New
14,999
-
$228,1350.0%$9.95
32

Other major holders of CAPR: BlackRock, Inc., STATE STREET CORP, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used